Genzyme Oncology, Inc.
Genzyme Oncology, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in the early 1980s, the company has established itself as a leader in developing innovative therapies for cancer treatment, focusing on rare and complex diseases. With a strong presence in North America and Europe, Genzyme Oncology is renowned for its commitment to advancing patient care through cutting-edge research and development.
The company’s core products include targeted therapies and biologics that address unmet medical needs in oncology. What sets Genzyme apart is its dedication to personalised medicine, ensuring that treatments are tailored to individual patient profiles. Over the years, Genzyme Oncology has achieved significant milestones, including numerous FDA approvals, solidifying its market position as a trusted provider of oncology solutions.
+62 vs industry average
Genzyme Oncology, Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Genzyme Oncology, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Genzyme Oncology, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Genzyme Oncology, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Genzyme Oncology, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Genzyme Oncology, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project